(ARW) Arrow Electronics - Ratings and Ratios
Semiconductors, Interconnect Components, Passive Components, Computing Solutions, Datacenter Services
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 26.7% |
| Value at Risk 5%th | 39.6% |
| Relative Tail Risk | -9.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -26.66 |
| CAGR/Max DD | 0.01 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.609 |
| Beta | 0.971 |
| Beta Downside | 0.759 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.16% |
| Mean DD | 14.66% |
| Median DD | 14.84% |
Description: ARW Arrow Electronics November 05, 2025
Arrow Electronics (NYSE:ARW) distributes electronic components and enterprise-computing solutions worldwide, operating through two segments: Global Components, which sells semiconductors, passive and electromechanical parts, and memory products; and Global Enterprise Computing Solutions, which provides data-center, cloud, security and analytics offerings plus related engineering, logistics and training services.
In FY 2024 the company generated roughly $34 billion in revenue, with the Global Components segment contributing about 70 % of sales and delivering a gross margin near 22 %, while the Enterprise Computing segment grew at a 9 % annual rate, reflecting rising demand for cloud-infrastructure hardware.
Key drivers for Arrow include the cyclical health of the semiconductor market, corporate IT-capex trends toward hybrid-cloud and edge computing, and the firm’s ability to leverage its extensive logistics network to mitigate supply-chain disruptions that have plagued many distributors.
For a deeper quantitative view of ARW’s valuation metrics, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (475.9m TTM) > 0 and > 6% of Revenue (6% = 1.76b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -4.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.79% (prev 19.50%; Δ 3.28pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 190.6m <= Net Income 475.9m (YES >=105%, WARN >=100%) |
| Net Debt (2.92b) to EBITDA (879.3m) ratio: 3.32 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (52.1m) change vs 12m ago -2.49% (target <= -2.0% for YES) |
| Gross Margin 11.10% (prev 12.21%; Δ -1.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 129.3% (prev 136.1%; Δ -6.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.03 (EBITDA TTM 879.3m / Interest Expense TTM 242.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.22
| (A) 0.27 = (Total Current Assets 21.14b - Total Current Liabilities 14.44b) / Total Assets 24.53b |
| (B) 0.26 = Retained Earnings (Balance) 6.36b / Total Assets 24.53b |
| (C) 0.03 = EBIT TTM 735.9m / Avg Total Assets 22.73b |
| (D) 0.35 = Book Value of Equity 6.25b / Total Liabilities 18.05b |
| Total Rating: 3.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 38.88
| 1. Piotroski 2.50pt |
| 2. FCF Yield 2.01% |
| 3. FCF Margin 0.57% |
| 4. Debt/Equity 0.49 |
| 5. Debt/Ebitda 3.32 |
| 6. ROIC - WACC (= 0.13)% |
| 7. RoE 7.79% |
| 8. Rev. Trend -83.21% |
| 9. EPS Trend -91.31% |
What is the price of ARW shares?
Over the past week, the price has changed by +2.15%, over one month by -8.68%, over three months by -14.83% and over the past year by -10.11%.
Is ARW a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the ARW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 108.3 | 0.2% |
| Analysts Target Price | 108.3 | 0.2% |
| ValueRay Target Price | 99.1 | -8.3% |
ARW Fundamental Data Overview November 26, 2025
P/E Trailing = 11.6865
P/E Forward = 4.7037
P/S = 0.1856
P/B = 0.851
P/EG = 0.8841
Beta = 1.04
Revenue TTM = 29.39b USD
EBIT TTM = 735.9m USD
EBITDA TTM = 879.3m USD
Long Term Debt = 3.12b USD (from longTermDebt, last quarter)
Short Term Debt = 10.8m USD (from shortTermDebt, last quarter)
Debt = 3.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.92b USD (from netDebt column, last quarter)
Enterprise Value = 8.37b USD (5.45b + Debt 3.13b - CCE 213.6m)
Interest Coverage Ratio = 3.03 (Ebit TTM 735.9m / Interest Expense TTM 242.9m)
FCF Yield = 2.01% (FCF TTM 168.0m / Enterprise Value 8.37b)
FCF Margin = 0.57% (FCF TTM 168.0m / Revenue TTM 29.39b)
Net Margin = 1.62% (Net Income TTM 475.9m / Revenue TTM 29.39b)
Gross Margin = 11.10% ((Revenue TTM 29.39b - Cost of Revenue TTM 26.13b) / Revenue TTM)
Gross Margin QoQ = 10.83% (prev 11.20%)
Tobins Q-Ratio = 0.34 (Enterprise Value 8.37b / Total Assets 24.53b)
Interest Expense / Debt = 2.11% (Interest Expense 66.0m / Debt 3.13b)
Taxrate = 15.16% (19.5m / 128.8m)
NOPAT = 624.3m (EBIT 735.9m * (1 - 15.16%))
Current Ratio = 1.46 (Total Current Assets 21.14b / Total Current Liabilities 14.44b)
Debt / Equity = 0.49 (Debt 3.13b / totalStockholderEquity, last quarter 6.40b)
Debt / EBITDA = 3.32 (Net Debt 2.92b / EBITDA 879.3m)
Debt / FCF = 17.35 (Net Debt 2.92b / FCF TTM 168.0m)
Total Stockholder Equity = 6.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.94% (Net Income 475.9m / Total Assets 24.53b)
RoE = 7.79% (Net Income TTM 475.9m / Total Stockholder Equity 6.11b)
RoCE = 7.98% (EBIT 735.9m / Capital Employed (Equity 6.11b + L.T.Debt 3.12b))
RoIC = 6.87% (NOPAT 624.3m / Invested Capital 9.08b)
WACC = 6.75% (E(5.45b)/V(8.58b) * Re(9.59%) + D(3.13b)/V(8.58b) * Rd(2.11%) * (1-Tc(0.15)))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.65%
[DCF Debug] Terminal Value 69.70% ; FCFE base≈498.8m ; Y1≈422.7m ; Y5≈322.1m
Fair Price DCF = 88.70 (DCF Value 4.57b / Shares Outstanding 51.5m; 5y FCF grow -18.50% → 3.0% )
EPS Correlation: -91.31 | EPS CAGR: -19.24% | SUE: 0.69 | # QB: 0
Revenue Correlation: -83.21 | Revenue CAGR: -4.08% | SUE: 0.16 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.29 | Chg30d=-0.500 | Revisions Net=-2 | Analysts=4
EPS current Year (2025-12-31): EPS=10.21 | Chg30d=-0.033 | Revisions Net=-2 | Growth EPS=-3.3% | Growth Revenue=+8.4%
EPS next Year (2026-12-31): EPS=11.78 | Chg30d=-2.443 | Revisions Net=-3 | Growth EPS=+15.4% | Growth Revenue=+4.2%
Additional Sources for ARW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle